RxDoctor Payments Data

Ingrid Olhoffer, MD

MOHS-Micrographic Surgery · Orangeburg, NYNPI 1487626651

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for mohs-micrographic surgery clinicians in NY, where the typical reported total is $1,291.

$1,243in general payments, 2019–2025

Across 58 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$178
  • AbbVie$174
  • Lilly USA, LLC$138
  • Regeneron Healthcare Solutions, Inc.$127
  • Sanofi$126
  • Amgen$90
  • plus $410 from 12 others

What the payments were for

  • Food & beverage$1,243100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,243 in reported general payments places this provider in the 45th percentile of 75 mohs-micrographic surgery providers in New York.

See all mohs-micrographic surgery providers in New York

Medicare billing

Part B allowed, 2024
$1,101,115
Medicare patients
770
Services billed
4,031

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin574$3,881
Gentamicin Sulfate70$2,577
Doxycycline Hyclate250$1,163
Tretinoin11$628
Metronidazole11$506
Ketoconazole19$404
Cephalexin40$151
Triamcinolone Acetonide19$128
Hydrocortisone17$75

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Orangeburg

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →